For many years now the hope of further advances in Stem Cell Multiple Sclerosis has been a bright spot on the horizon for sufferers of the crippling disease and the Researchers trying to cure and treat it. Stem Cell MS Treatment is being researched worldwide and has been in trial on humans and animals. Researching Stem Cell Multiple Sclerosis methods is an expensive proposition and government has been an unreliable source of money because of the controversy that swirls around the use of embryonic stem cells.

Enter Fast Forward, a nonprofit subsidiary arm of the National Multiple Sclerosis Society. They announced in October of 2011 that they will enter into an alliance with Athersys, Inc to develop further the stem cell MS treatment known as MultiStem. They are infusing $640,000 into the alliance with the hopes they can gain FDA approval faster to use the off the shelf Stem Cell MS drug. Even more significant, perhaps, is that the approval being sought is to go into human trials with the Stem Cell Multiple Sclerosis approach.


MultiStem showing some promising results in stem cell MS treatments on the chronic-progressive form of the disease


MultiStem has shown positive results in early studies in treating many disease indications in the areas of cardiovascular, neurological, and the inflammatory immune diseases. The drug company has four programs that have advanced to the clinical stage, although none of them involve stem cell Multiple Sclerosis disease treatments yet. And that is where this money from Fast Forward comes in. The drug company will use the money to research the drug on stem cell ms dosages in mice. Once they get the dosage right in mice, the goal will be to be able to submit an application to the FDA and gain approval to begin the trials in humans.

The project will be done at Case Western University under the direction of Dr. Robert Miller, a prominent MS researcher and the publisher of over 120 papers on neural diseases. He is also one of the founding members of the Myelin Repair Foundation whose primary mission is to get new therapies, including stem cell ms therapies, rapidly approved. Even though final approval might be as far as 10 years away, in the world of pharmaceutical research that is fast. Stem cell Multiple Sclerosis treatment is the next great hope in the ultimate cure of all forms of MS and anything that can be done to speed things up is welcome by the MS community.